Next Generation Sequencing Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

1 RESEARCH SCOPE

1.1 Research Product Definition

1.2 Research Segmentation

1.2.1 Product Type

1.2.2 Main product Type of Major Players

1.3 Demand Overview

1.4 Research Methodology

2 GLOBAL NEXT GENERATION SEQUENCING INDUSTRY

2.1 Summary about Next Generation Sequencing Industry

2.2 Next Generation Sequencing Market Trends

2.2.1 Next Generation Sequencing Production & Consumption Trends

2.2.2 Next Generation Sequencing Demand Structure Trends

2.3 Next Generation Sequencing Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020

3.2 Market Development under the Impact of COVID-19

3.2.1 Drivers

3.2.2 Restraints

3.2.3 Opportunity

3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)

4.1.1 North America (U.S., Canada and Mexico)

4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)

4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)

4.1.4 South America (Brazil,, Argentina, Rest of Latin America)

4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)

4.2 Product Type Segmentation (2017 to 2021f)

4.2.1 454-Sequencing 

4.2.2 Illumina Sequencing 

4.2.3 Others

4.3 Consumption Segmentation (2017 to 2021f)

4.3.1 Oncology 

4.3.2 Hereditary Disease Detection 

4.3.3 Life Science

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)

5.1.1 U.S.

5.1.2 Canada

5.1.3 Mexico

5.2 Product Type Segmentation (2017 to 2021f)

5.2.1 454-Sequencing 

5.2.2 Illumina Sequencing 

5.2.3 Others

5.3 Consumption Segmentation (2017 to 2021f)

5.3.1 Oncology 

5.3.2 Hereditary Disease Detection 

5.3.3 Life Science

5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)

6.1.1 Germany

6.1.2 UK

6.1.3 France

6.1.4 Italy

6.1.5 Rest of Europe

6.2 Product Type Segmentation (2017 to 2021f)

6.2.1 454-Sequencing 

6.2.2 Illumina Sequencing 

6.2.3 Others

6.3 Consumption Segmentation (2017 to 2021f)

6.3.1 Oncology 

6.3.2 Hereditary Disease Detection 

6.3.3 Life Science

6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)

7.1.1 China

7.1.2 India

7.1.3 Japan

7.1.4 South Korea

7.1.5 Southeast Asia

7.1.6 Australia

7.1.7 Rest of Asia Pacific

7.2 Product Type Segmentation (2017 to 2021f)

7.2.1 454-Sequencing 

7.2.2 Illumina Sequencing 

7.2.3 Others

7.3 Consumption Segmentation (2017 to 2021f)

7.3.1 Oncology 

7.3.2 Hereditary Disease Detection 

7.3.3 Life Science

7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)

8.1.1 Brazil

8.1.2 Argentina

8.1.3 Rest of Latin America

8.2 Product Type Segmentation (2017 to 2021f)

8.2.1 454-Sequencing 

8.2.2 Illumina Sequencing 

8.2.3 Others

8.3 Consumption Segmentation (2017 to 2021f)

8.3.1 Oncology 

8.3.2 Hereditary Disease Detection 

8.3.3 Life Science

8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)

9.1.1 GCC

9.1.2 North Africa

9.1.3 South Africa

9.1.4 Rest of Middle East and Africa

9.2 Product Type Segmentation (2017 to 2021f)

9.2.1 454-Sequencing 

9.2.2 Illumina Sequencing 

9.2.3 Others

9.3 Consumption Segmentation (2017 to 2021f)

9.3.1 Oncology 

9.3.2 Hereditary Disease Detection 

9.3.3 Life Science

9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players

10.1.1 Thermo Fisher Scientific 

10.1.2 Illumina 

10.1.3 Roche Sequencing 

10.1.4 Pacific Biosciences 

10.1.5 BGI 

10.1.6 Novo gene 

10.1.7 Biomarker 

10.1.8 Roche 

10.1.9 Daan Gene 

10.1.10 Berry Genomics

10.2 Next Generation Sequencing Sales Date of Major Players (2017-2020e)

10.2.1 Thermo Fisher Scientific 

10.2.2 Illumina 

10.2.3 Roche Sequencing 

10.2.4 Pacific Biosciences 

10.2.5 BGI 

10.2.6 Novo gene 

10.2.7 Biomarker 

10.2.8 Roche 

10.2.9 Daan Gene 

10.2.10 Berry Genomics

10.3 Market Distribution of Major Players

10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region

11.2 Forecast by Demand

11.3 Environment Forecast

11.3.1 Impact of COVID-19

11.3.2 Geopolitics Overview

11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT

Table Next Generation Sequencing Product Type Overview

Table Next Generation Sequencing Product Type Market Share List

Table Next Generation Sequencing Product Type of Major Players

Table Brief Introduction of Thermo Fisher Scientific 

Table Brief Introduction of Illumina 

Table Brief Introduction of Roche Sequencing 

Table Brief Introduction of Pacific Biosciences 

Table Brief Introduction of BGI 

Table Brief Introduction of Novo gene 

Table Brief Introduction of Biomarker 

Table Brief Introduction of Roche 

Table Brief Introduction of Daan Gene 

Table Brief Introduction of Berry Genomics

Table Products & Services of Thermo Fisher Scientific 

Table Products & Services of Illumina 

Table Products & Services of Roche Sequencing 

Table Products & Services of Pacific Biosciences 

Table Products & Services of BGI 

Table Products & Services of Novo gene 

Table Products & Services of Biomarker 

Table Products & Services of Roche 

Table Products & Services of Daan Gene 

Table Products & Services of Berry Genomics

Table Market Distribution of Major Players

Table Global Major Players Sales Revenue (Million USD) 2017-2020e

Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e

Table Global Next Generation Sequencing Market Forecast (Million USD) by Region 2021f-2026f

Table Global Next Generation Sequencing Market Forecast (Million USD) Share by Region 2021f-2026f

Table Global Next Generation Sequencing Market Forecast (Million USD) by Demand 2021f-2026f

Table Global Next Generation Sequencing Market Forecast (Million USD) Share by Demand 2021f-2026f